UNITY Biotechnology (UBX)
(Delayed Data from NSDQ)
$1.55 USD
-0.01 (-0.64%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.57 +0.02 (1.29%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.44 | 0.00% |
Earnings Summary
For their last quarter, UNITY Biotechnology (UBX) reported earnings of -$0.34 per share, beating the Zacks Consensus Estimate of $-0.57 per share. This reflects a positive earnings surprise of 40.35%. Look out for UBX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.44 per share, reflecting a year-over-year increase of 48.24%.
Earnings History
Price & Consensus
Zacks News for UBX
Unity (UNX) Down on Disappointing Results From Wet AMD Study
UBX: What are Zacks experts saying now?
Zacks Private Portfolio Services